AIC
ANIK icon

Archer Investment Corporation’s Anika Therapeutics ANIK Stock Holding History

Archer Investment Corporation’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-106
Closed -$5K – 593
2019
Q4 		$5K Hold
106
– – ﹤0.01% 501
2019
Q3 		$6K Buy
+106
New +$5.44K ﹤0.01% 375

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Archer Investment Corporation's ANIK Position: Q1 2020 in Review

Archer Investment Corporation sold out of Anika Therapeutics (ANIK) in Q1 2020, closing a stake of 106 shares — an estimated $5K sold.

Archer Investment Corporation first reported a position in ANIK in Q3 2019 and held it in 2 quarters. The position peaked at $6K in Q3 2019. 164 funds tracked by Wall St. Rank hold ANIK as of Q1 2020.

  • Archer Investment Corporation reported no remaining Anika Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Archer Investment Corporation sold 106 Anika Therapeutics shares in Q1 2020, an estimated $5K.
  • Archer Investment Corporation first reported a position in Anika Therapeutics in Q3 2019 and held it in 2 quarters.
  • Archer Investment Corporation's Anika Therapeutics position peaked at $6K in Q3 2019.
  • 164 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2020.

Based on Archer Investment Corporation's 13F filing for Q1 2020, filed 7 May 2020.